Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-04-04
DOI
https://doi.org/10.7326/annals-24-03849
Citations
6
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
7.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide

Anita Y. M. Kwan, Linsey Winne, Elisa Gomez‐Valderas, Palash Sharma et al.
6 citations
Annals of Internal Medicine
Diabetes Treatment and Management
7.77
article

Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide

Anita Y. M. Kwan, Linsey Winne, Elisa Gomez‐Valderas, Palash Sharma, Liana K. Billings, Krishna Karthik Chivukula
article en
6 citations

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(5)
Eli Lilly (United States) (US), University of Chicago (US)
Zero hunger
Openalex Percentile: Top 3%
Diabetes Treatment and Management
7.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.